REBYOTA® Support & Resources

You may qualify for financial assistance through Ferring Pharmaceuticals.

REBYOTA Patient Portrayal

REBYOTA Co-pay Program

Commercially insured, eligible PATIENTS MAY PAY AS LITTLE AS $100a for each REBYOTA prescription.

aAvailable only for patients who meet eligibility requirements. The program does not cover the cost of administration, office visits, or any associated costs. Terms and conditions apply. Offer expires 12/31/24.

See additional terms and conditions below.

To enroll in the REBYOTA Co-pay Program, please speak with your doctor.
For additional assistance, call 1-877-REBYOTA

REBYOTA Patient Assistance Programa

You may be eligible to receive REBYOTA at no cost if you qualify for the Ferring REBYOTA Patient Assistance Program (PAP). Simply ask your doctor’s office to enroll on your behalf through REBYOTA Connect.

aAvailable only for patients who meet eligibility requirements. The program does not cover the cost of administration, office visits, or any associated costs. Terms and conditions apply. Offer expires 12/31/24.

See additional terms and conditions below.

To learn more about the REBYOTA Patient Assistance Program
and to see if you qualify, please speak with your doctor.

Flowers on a vine

Patient Testimonials

See how REBYOTA has helped people keep recurrent C. diff infection from coming back. These are some of their inspiring stories.

Melissa’s story

Had REBYOTA been available sooner, I would have asked for it.

– Melissa, Clinical Study Patient

Most common side effects may include stomach pain, 
diarrhea, bloating, gas, and nausea.1

 

Individual results may vary.

For more information, please talk to your doctor and see full Prescribing Information. Melissa was compensated for her time.

Melissa’s Story: REBYOTA Patient Testimonial

Freda’s story

I just knew that if I had C. diff again,
 I wasn’t going to survive. But my C. diff didn’t
 come back after I had REBYOTA.

– Freda, Clinical Study Patient

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.1

 

Individual results may vary.

For more information, please talk to your doctor and see full Prescribing Information. Freda was compensated for her time.

Freda’s Story: REBYOTA Patient Testimonial

Patricia’s story

For me, it was one dose and one visit, and that was it.

– Patricia, Clinical Study Patient

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.1

 

Individual results may vary.

For more information, please talk to your doctor and see full Prescribing Information. Patricia was compensated for her time.

Patricia’s Story: REBYOTA Patient Testimonial

Heather’s story

It has been six months since REBYOTA. I have 
not had another recurrence.

– Heather, Actual REBYOTA Patient

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.1

 

Individual results may vary.

For more information, please talk to your doctor and see full Prescribing Information. Heather was compensated for her time.

Heather, Actual REBYOTA patient

Share your story

Have you received REBYOTA to keep your recurrent C. diff from coming back?

Share Your REBYOTA Story

Have you received REBYOTA and want to share your story with others?
Fill out the form below and we will contact you for more information.

Preferred communication method*(Required)
Have you or a loved one been treated with REBYOTA?*(Required)

*Required field.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

REBYOTA care resources

Resources to help you and others (including caregivers) who may be coping with recurrent C. diff infection.

C. diff Caregiver Checklist

Caregiver checklist

This caregiver checklist will help you take care of your loved ones with recurrent C. diff infection.

Submit
C. diff Patient Diary

C. diff diary

Prepare for your doctor appointments with this printable C. diff diary. Track medical history, symptoms, questions, food and water intake, and more.

Submit
REBYOTA Patient Brochure

Patient brochure

Learn more about recurrent C. diff infection and how to keep it from coming back with REBYOTA.

Submit

Join an Online Research Panel

Have you suffered with C. diff or cared for someone who has? Or have you recently been administered REBYOTA? If so, please join an online research panel and help others living with C. diff.

Keep your recurrent C. diff infection from coming back

Learn how REBYOTA—in one dose, one visit—can keep your recurrent C. diff infection from coming back.

Keep exploring REBYOTA

About REBYOTA

Learn how one dose of REBYOTA can keep C. diff from coming back.

About REBYOTA

Getting REBYOTA

Learn how REBYOTA can be administered at your doctor’s office or in your home.

Getting REBYOTA

Sign up for more information

Receive additional information and resources to help you through your C. diff infection journey.

What’s your experience with C. diff infection?*(Required)

*Required field.

Please see Important Safety Information and full Prescribing Information

INDICATION

REBYOTA (fecal microbiota, live – jslm) is indicated for the prevention of recurrence of Clostridioides difficile (C. diff) infection in individuals 18 years of age and older, following antibiotic treatment for recurrent C. diff infection.
Limitation of Use
REBYOTA is not indicated for the treatment of C. diff infection.

Important Safety Information

  • You should not receive REBYOTA if you have a history of a severe allergic reaction (e.g., anaphylaxis) to REBYOTA or any of its components.
  • You should report to your doctor any infection you think you may have acquired after administration.
  • REBYOTA may contain food allergens.
  • Most common side effects may include stomach pain (8.9%), diarrhea (7.2%), bloating (3.9%), gas (3.3%), and nausea (3.3%).
  • REBYOTA has not been studied in patients below 18 years of age.
  • Clinical studies did not determine if adults 65 years of age and older responded differently than younger adults.

You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-332-1088.

Please click to see the full Prescribing Information.

You are leaving REBYOTA.com

The link you have selected will direct you to a site or resource outside of our website.
Thank you.